Sökresultat - Alice T. Shaw

Förfina resultatet
  1. 1
    <i>ALK</i> in Lung Cancer: Past, Present, and Future

    <i>ALK</i> in Lung Cancer: Past, Present, and Future av Alice T. Shaw, Jeffrey A. Engelman

    Publicerad 2013
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  2. 2
    Novel Targets in Non-Small Cell Lung Cancer: <i>ROS1</i> and <i>RET</i> Fusions

    Novel Targets in Non-Small Cell Lung Cancer: <i>ROS1</i> and <i>RET</i> Fusions av Justin F. Gainor, Alice T. Shaw

    Publicerad 2013
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  3. 3
    Molecular Pathways: Resistance to Kinase Inhibitors and Implications for Therapeutic Strategies

    Molecular Pathways: Resistance to Kinase Inhibitors and Implications for Therapeutic Strategies av Christine M. Lovly, Alice T. Shaw

    Publicerad 2014
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  4. 4
    Emerging Paradigms in the Development of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer

    Emerging Paradigms in the Development of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer av Justin F. Gainor, Alice T. Shaw

    Publicerad 2013
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  5. 5
    Resisting Resistance: Targeted Therapies in Lung Cancer

    Resisting Resistance: Targeted Therapies in Lung Cancer av W. Marston Linehan, Alice T. Shaw

    Publicerad 2016
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  6. 6
    Crizotinib resistance: implications for therapeutic strategies

    Crizotinib resistance: implications for therapeutic strategies av Ibiayi Dagogo‐Jack, Alice T. Shaw

    Publicerad 2016
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  7. 7
    Recent Advances in Targeting ROS1 in Lung Cancer

    Recent Advances in Targeting ROS1 in Lung Cancer av W. Marston Linehan, Alice T. Shaw

    Publicerad 2017
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  8. 8
    Therapeutic Targeting of Anaplastic Lymphoma Kinase in Lung Cancer: A Paradigm for Precision Cancer Medicine

    Therapeutic Targeting of Anaplastic Lymphoma Kinase in Lung Cancer: A Paradigm for Precision Cancer Medicine av Ryohei Katayama, Christine M. Lovly, Alice T. Shaw

    Publicerad 2015
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  9. 9
    Targeting ALK: Precision Medicine Takes on Drug Resistance

    Targeting ALK: Precision Medicine Takes on Drug Resistance av W. Marston Linehan, Gregory J. Riely, Alice T. Shaw

    Publicerad 2017
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  10. 10
    Tyrosine kinase gene rearrangements in epithelial malignancies

    Tyrosine kinase gene rearrangements in epithelial malignancies av Alice T. Shaw, Peggy P. Hsu, Mark M. Awad, Jeffrey A. Engelman

    Publicerad 2013
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  11. 11
    The Central Nervous System as a Sanctuary Site in ALK-Positive Non–Small-Cell Lung Cancer

    The Central Nervous System as a Sanctuary Site in ALK-Positive Non–Small-Cell Lung Cancer av Justin F. Gainor, Sai‐Hong Ignatius Ou, Jennifer Logan, Lawrence F. Borges, Alice T. Shaw

    Publicerad 2013
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  12. 12
    Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Cancer

    Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Cancer av Meghan Campo, H. Al-Halabi, Melin J. Khandekar, Alice T. Shaw, Lecia V. Sequist, Henning Willers

    Publicerad 2016
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  13. 13
    Clinical Management of Adverse Events Associated with Lorlatinib

    Clinical Management of Adverse Events Associated with Lorlatinib av Todd M. Bauer, Enriqueta Felip, Benjamin Solomon, Holger Thurm, Gerson Peltz, Marc Chioda, Alice T. Shaw

    Publicerad 2019
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  14. 14
    Cabozantinib Overcomes Crizotinib Resistance in ROS1 Fusion–Positive Cancer

    Cabozantinib Overcomes Crizotinib Resistance in ROS1 Fusion–Positive Cancer av Ryohei Katayama, Yuka Kobayashi, Luc Friboulet, Elizabeth L. Lockerman, Sumie Koike, Alice T. Shaw, Jeffrey A. Engelman, Naoya Fujita

    Publicerad 2014
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  15. 15
    Osimertinib Responses After Disease Progression in Patients Who Had Been Receiving Rociletinib

    Osimertinib Responses After Disease Progression in Patients Who Had Been Receiving Rociletinib av Lecia V. Sequist, Zofia Piotrowska, Matthew J. Niederst, Rebecca S. Heist, Subba R. Digumarthy, Alice T. Shaw, Jeffrey A. Engelman

    Publicerad 2015
    Hämta fulltext Hämta fulltext
    Carta
    Lägg till i favoriter
    Sparad:
  16. 16
    Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer Relapsing on Standard Dose Alectinib

    Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer Relapsing on Standard Dose Alec... av Justin F. Gainor, S. Andrew, Jennifer Logan, Ranliang Hu, Kevin Oh, Priscilla K. Brastianos, Helen A. Shih, Alice T. Shaw

    Publicerad 2015
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  17. 17
    Nutrient intakes during pregnancy: observations on the influence of smoking and social class

    Nutrient intakes during pregnancy: observations on the influence of smoking and social class av F.M. Haste, OG Brooke, H R Anderson, J Martin Bland, Alice T. Shaw, Jane C. Griffin, Janet L. Peacock

    Publicerad 1990
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  18. 18
    Alectinib Salvages CNS Relapses in ALK-Positive Lung Cancer Patients Previously Treated with Crizotinib and Ceritinib

    Alectinib Salvages CNS Relapses in ALK-Positive Lung Cancer Patients Previously Treated with Crizotinib and Ceritinib av Justin F. Gainor, Carol A. Sherman, Kathryn Willoughby, Jennifer Logan, Elizabeth A. Kennedy, Priscilla K. Brastianos, S. Andrew, Alice T. Shaw

    Publicerad 2015
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  19. 19
    Emergence of a RET V804M Gatekeeper Mutation During Treatment With Vandetanib in RET-Rearranged NSCLC

    Emergence of a RET V804M Gatekeeper Mutation During Treatment With Vandetanib in RET-Rearranged NSCLC av Ibiayi Dagogo‐Jack, Sara E. Stevens, W. Marston Linehan, Rebecca J. Nagy, Lorin A. Ferris, Alice T. Shaw, Justin F. Gainor

    Publicerad 2018
    Hämta fulltext Hämta fulltext
    Carta
    Lägg till i favoriter
    Sparad:
  20. 20
    ALK Mutation Status Before and After Alectinib Treatment in Locally Advanced or Metastatic ALK-Positive NSCLC: Pooled Analysis of Two Prospective Trials

    ALK Mutation Status Before and After Alectinib Treatment in Locally Advanced or Metastatic ALK-Positive NSCLC: Pooled Analysis of Two Prospective Trials av Johannes Noé, Alex Lovejoy, Sai‐Hong Ignatius Ou, Stephanie J. Yaung, Walter Bordogna, Daniel M. Klass, Craig Cummings, Alice T. Shaw

    Publicerad 2019
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: